Skip to content
Clinical Trials – home

Medical University Of Lausitz Carl Thiem

Verifiedinfo

Germany Thiemstrasse 111, Spremberger Vorstadt, 03048 Cottbus, Germany

  • 13 trials recruiting
  • Plasma cell myeloma · Breast cancer female · Breast cancer male
  • Adults and children

About Specializations

Medical University Of Lausitz Carl Thiem in Cottbus, Germany specialises in clinical trials of conditions such as Plasma cell myeloma, Breast cancer female, Breast cancer male, Breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Hematology and Oncology

The medical center is at the forefront of hematology and oncology research, focusing on innovative treatments for blood disorders and cancers. The center's commitment to advancing therapeutic strategies is evident in its comprehensive research programs.

  • Myeloid Leukemia in Children
  • Down Syndrome-Associated Leukemia
  • Novel Chemotherapeutic Approaches

By integrating cutting-edge research with clinical applications, the center is enhancing the understanding and treatment of complex hematological conditions, particularly in pediatric populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Thiemstrasse 111, Spremberger Vorstadt03048 CottbusGermany
Recruiting now
13 trials
Conditions studied
20
Partner status
Verified

More sites in CottbusGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

18 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Goserelin Acetate
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elacestrant
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Kura Oncology Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pabinafusp Alfa
  • Sponsor:Jcr Pharmaceuticals Co. Ltd.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fazirsiran
  • Sponsor:Takeda Development Center Americas Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fazirsiran
  • Sponsor:Takeda Development Center Americas Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.